-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Angiodynamics Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Angiodynamics Inc Deferred Income Tax Expense (Benefit) for the quarter ending August 31, 2023 was -$11.4 M, a 1159% decline year-over-year.
- Angiodynamics Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$2.31 M, a 37.7% increase from 2021.
- Angiodynamics Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$3.71 M, a 22.8% increase from 2020.
- Angiodynamics Inc annual Deferred Income Tax Expense (Benefit) for 2020 was -$4.81 M, a 206% decline from 2019.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)